Treatments & Interventions
Procarbazine hydrochloride
substance
Bleomycin sulfate
substance
Streptozocin
substance
Doxorubicin hydrochloride
substance
Vinorelbine tartrate
substance
Sargramostim
substance
Vinorelbine
substance
Mechlorethamine
substance
Doxorubicin
substance
Bleomycin
substance
Ifosfamide
substance
Vinblastine
substance
Mechlorethamine hydrochloride
substance
Vinblastine sulphate
substance
Vincristine
substance
Lomustine
substance
Chlorambucil
substance
Carmustine
substance
Cisplatin
substance
Cyclophosphamide
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 118605002
- UMLS CUI
- C1334968
- Fully Specified Name
- Hodgkin lymphoma, nodular lymphocyte predominance (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 17
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.